Keytruda is predicted to be the best-selling drug by annual revenue in 2023. MSD has announced a new deal with Promega – a company providing solutions and technical support to the life sciences ...
Owkin to collaborate with MSD to develop and commercialize AI-powered digital pathology Microsatellite Instability High (MSI-H) diagnostics for four types of cancer. The aim is to pre-screen patients ...
PARIS--(BUSINESS WIRE)--Owkin, a French-American biotechnology company that applies artificial intelligence (AI) to drug discovery, development, and diagnostics, today announced that it has entered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback